Back pain: easy is the new difficult?
DOI: 10.32364/2587-6821-2021-5-10-642-647
O.V. Kurushina, A.E. Barulin
Volgograd State Medical University, Volgograd, Russian Federation
Back pain is one of the most common pain syndromes affecting significantly working capacity and quality of life. In the future, back pain is predicted to grow due to a higher rate of comorbidities and conditions (i.e., obesity, smoking, sedentary lifestyle) and population aging. Therefore, back pain relief is an essential issue for various specialists. However, despite a growing body of studies and published data, the issue of the management of patients with back pain is far from being resolved. This paper discusses the efficacy and safety of various therapeutic strategies for back pain treatment, focusing on B vitamins. Analgesic properties plus the enhancement of painkiller effects and lower risk of pain chronicity (as a result of reduced peripheral and central sensitization) favor including B vitamins into treatment regimens for back pain. The authors also address non-pharmacological approaches to back pain and emphasize that a long-lasting effect of analgesics cannot be ac hieved without switching from reducing acute pain to preventing future exacerbations.
Keywords: back pain, B vitamins, biopsychosocial model, adjuvant treatment, manual therapy.
For citation: Kurushina O.V., Barulin A.E. Back pain: easy is the new difficult? Russian Medical Inquiry. 2021;5(10):642–647 (in Russ.). DOI: 10.32364/2587-6821-2021-5-10-642-647.
About the authors:
Olga V. Kurushina — Dr. Sc. (Med.), Head of the Department of Neurology, Neurosurgery, and Medical Genetics, Volgograd State Medical University; 1, Pavshikh Bortsov sq., Volgograd, 400131, Russian Federation; ORCID iD 0000-0003-4364-0123.
Aleksandr E. Barulin — Dr. Sc. (Med.), Head of the Department of Neurology, Psychiatry, Manual Medicine, and Medical Rehabilitation, Institute of Continuous Medical and Pharmaceutical Education, Volgograd State Medical University; 1, Pavshikh Bortsov sq., Volgograd, 400131, Russian Federation; ORCID iD 0000-0001-7264-3580.
Contact information: Olga V. Kurushina, e-mail: ovkurushina@mail.ru.
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interests.
Received 14.07.2021.
Revised 06.08.2021.
Accepted 31.08.2021.
2. Hoy D., Bain C., Williams G. et al. A systematic review of the global prevalence of low back pain. Arthritis Rheum. 2012;64(6):2028–37. DOI: 10.1002/art.34347.
3. Andersson G.B. Epidemiological features of chronic low-back pain. Lancet. 1999;354:581–585. DOI: 10.1016/S0140-6736(99)01312-4.
4. Manchikanti L., Singh V., Falco F.J. E. et al. Epidemiology of low back pain in adults. Neuromodulation 2014;17(Suppl 2):3–10. DOI: 10.1111/ner.12018.
5. Selkirk S.M., Ruff R. Low back pain, radiculopathy. Handb Clin Neurol. 2016;136:1027–1033. DOI: 10.1016/B978-0-444-53486-6.00053-3.
6. GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–1922. DOI: 10.1016/S0140-6736(18)32335-3.
7. Kurushina O.V., Barulin A.E. Back pain: gender characteristics. Saratovskiy nauchno-meditsinskiy zhurnal. 2012;8(2):477–481 (in Russ.).
8. Tretyakova E.A., Karakulova Yu.V. Clinical and biochemical study of the mechanisms of the formation of chronic pain in the lower back. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2011;8:58–61 (in Russ.).
9. Battié M.C., Videman T., Kaprio J. et al. The twin spine study: Contributions to a changing view of disc degeneration. Spine J. 2009;9:47–59. DOI: 10.1016/j.spinee.2008.11.011.
10. Duggleby T., Kumar S. Epidemiology of juvenile low back pain: a review. Disabil Rehabil. 1997;19:505–512.
11. Deyo R.A., Andersson G., Bombardier C. et al. Outcome measures for studying patients with low back pain. Spine. 1994;19:2032S–2036S.
12. Levin O.S. Modern approaches to the diagnosis and treatment of back pain. M.; 2006 (in Russ.).
13. Maroudas A., Stockwell R.A., Nachemson A., Urban J. Factors involved in the nutrition of the human lumbar intervertebral disc: Cellularity and diffusion of glucose in vitro. J Anat. 1975;120:113–130.
14. Barulin A.E., Kurushina O.V., Drushlyakova A.A. et al. Physiological substantiation of the stress-factor component on the formation of static-dynamic disorders. Rossiyskiy zhurnal boli. 2017;1(52):6 (in Russ.).
15. Danilov A.B. Pain management. Biopsychosocial approach. M.: AMM PRESS; 2012 (in Russ.).
16. Deyo R.A., Mirza S.K., Turner J.A., Martin B.I. Overtreating chronic back pain: time to back off? J Am Board Fam Med. 2009;22:62–68. DOI: 10.3122/jabfm.2009.01.080102.
17. Barantsevich E., Andreev V. Possibilities of treating chronic pain in lumbosacral radiculopathy. Vrach. 2012;11:13–19 (in Russ.).
18. Levin O.S. Diagnostics and treatment of neurological manifestations of spinal osteochondrosis. Consilium medicum. 2004;6:547–554 (in Russ.).
19. Kukushkin M.L. Diagnosis and treatment of non-specific back pain. Neurology and Psychiatry. 2012;4:2–6 (in Russ.).
20. Kuhlwein A., Meyer H.J., Koehler C.O. [Reduced diclofenac administration by B vitamins: results of a randomized double-blind study with reduced daily doses of diclofenac (75 mg diclofenac versus 75 mg diclofenac plus B vitamins) in acute lumbar vertebral syndromes]. Klin Wochenschr. 1990;68(2):107–115 (in German).DOI: 10.1007/BF01646857.
21. Brüggemann G., Koehler C.O., Koch E.M. [Results of a double-blind study of diclofenac + vitamin B1, B6, B12 versus diclofenac in patients with acute pain of the lumbar vertebrae. A multicenter study]. Klin Wochenschr. 1990;68(2):116–120.
22. Vetter G., Brüggemann G., Lettko M. et al. Shortening diclofenac therapy by B vitamins. Results of a randomized double-blind study, diclofenac 50 mg versus diclofenac 50 mg plus B vitamins, in painful spinal diseases with degenerative changes. Z Rheumatol. 1988;47(5):351–362.
23. Song X-S., Huang Z-J., Song X-J. Thiamine suppresses thermal hyperalgesia, inhibits hyperexcitability, and lessens alterations of sodium currents in injured, dorsal root ganglion neurons in rats. Anesthesiology 2009;110(2):387–400. DOI: 10.1097/ALN.0b013e3181942f1e.
24. Thériault O., Poulin H., Thomas G.R. et al. Pyridoxal-5’-phosphate (MC-1), a vitamin B6 derivative, inhibits expressed P2X receptors. Can J Physiol Pharmacol. 2014;92(3):189–196.
25. Chiang E-P., Smith D.E., Selhub J. et al. Inflammation causes tissue-specific depletion of vitamin B6. Arthritis Res Ther. 2005;7(6):R1254–1262. DOI: 10.1186/ar1821.
26. Erfanparast A., Tamaddonfard E. Effects of intracortical microinjection of vitamin B12 on penicillin-induced epileptiform activity in rats. Acta Neurobiol Exp (Wars). 2015;75(2):200–207.
27. Hosseinzadeh H., Moallem S.A., Moshiri M. et al. Anti-nociceptive and anti-inflammatory effects of cyanocobalamin (vitamin B12) against acute and chronic pain and inflammation in mice. Arzneimittelforschung. 2012;62(7):324–329. DOI: 10.1055/s-0032-1311635.
28. Moallem S.A., Hosseinzadeh H., Farahi S. A study of acute and chronic anti-nociceptive and anti-inflammatory effects of thiamine in mice. Iran Biomed J. 2008;12(3):173–138.
29. McCarty M.F. High-dose pyridoxine as an "anti-stress" strategy. Med Hypotheses. 2000;54(5):803–807. DOI: 10.1054/mehy.1999.0955.
30. Deng X.-T., Han Y., Liu W.-T., Song X.-J. B Vitamins potentiate acute morphine antinociception and attenuate the development of tolerance to chronic morphine in mice. Pain Med. 2017;18(10):1961–1974. DOI: 10.1093/pm/pnw358.
31. Menezes R.R., Godin A.M., Rodrigues F.F. et al. Thiamine and riboflavin inhibit production of cytokines and increase the anti-inflammatory activity of a corticosteroid in a chronic model of inflammation induced by complete Freund’s adjuvant. Pharmacol Rep 2017;69(5):1036–1043. DOI: 10.1016/j.pharep.2017.04.011.
32. Onk D., Mammadov R., Suleyman B. et al. The effect of thiamine and its metabolites on peripheral neuropathic pain induced by cisplatin in rats. Exp Anim. 2018;67(2):259–269. DOI: 10.1538/expanim.17-0090.
33. Khoromi S., Patsalides A., Parada S. et al. Topiramate in chronic lumbar radicular pain. J Pain. 2005;6(12):829–836. DOI: 10.1016/j.jpain.2005.08.002.
34. Mauro G.L., Martorana U., Cataldo P. et al. Vitamin B12 in low back pain: a randomised, double-blind, placebo-controlled study. Eur Rev Med Pharmacol Sci. 2000;4(3):53–58.
35. Bates C.J., Pentieva K.D., Prentice A. et al. Plasma pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 years and over. Br J Nutr. 1999;81:191–201.
36. Cattaneo M. Hyperhomocysteinemia: a risk factor for arterial and venous thrombotic disease. Int J Clin Lab Res. 1997;27:139–144.
37. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843. DOI: 10.1056/NEJM200003233421202.
38. Chiang E.-P., Smith D.E., Selhub J. et al. Inflammation causes tissue-specific depletion of vitamin B. Arthritis Res. 2005;7:R1254–R1262. DOI: 10.1186/ar1821.
39. Mibielli M.A., Geller M., Cohen J.C. et al. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study. Curr Med Res Opin. 2009;25(11):2589–2599. DOI: 10.3111/13696990903246911.
40. Mimenza Alvarado A., Aguilar Navarro S. Clinical Trial Assessing the Efficacy of Gabapentin Plus B Complex (B1/B12) versus Pregabalin for Treating Painful Diabetic Neuropathy. J Diabetes Res. 2016;2016:4078695. DOI: 10.1155/2016/4078695.
41. Danilov A.B. Treatment of acute back pain: B vitamins or NSAIDs. RMJ. 2010;18(31):35–40 (in Russ.).
42. Stracke H., Hammes H.P., Werkmann D. et al. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats. Exp Clin Endocrinol Diabetes. 2001;109(6):330–336. DOI: 10.1055/s-2001-17399.
43. Barulin A.E., Kurushina O.V., Puchkov A.E. Complex treatment of acute non-specific pain in the lower back. Neurology, neuropsychiatry, psychosomatics. 2014;3:38–42 (in Russ.).
44. Apeldoorn A.T., Bosmans J.E., Ostelo R.W. et al. Cost-effectiveness of a classification-based system for sub-acute and chronic low back pain. Eur Spine J. 2012;21:1290–1300. DOI: 10.1007/s00586-011-2144-4.
45. Beneciuk J.M., Bishop M.D., Fritz J.M. et al. The STarT back screening tool and individual psychological measures: evaluation of prognostic capabilities for low back pain clinical outcomes in outpatient physical therapy settings. Phys Ther. 2013;93:321–333. DOI: 10.2522/ptj.20120207.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
